Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""gp41"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 2173 results
Title:
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
Authors:
Tong T; San Diego Biomedical Research Institute, San Diego, California, United States of America.
D'Addabbo A; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Xu J; San Diego Biomedical Research Institute, San Diego, California, United States of America.
Chawla H; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Nguyen A; San Diego Biomedical Research Institute, San Diego, California, United States of America.
Ochoa P; San Diego Biomedical Research Institute, San Diego, California, United States of America.
Crispin M; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Binley JM; San Diego Biomedical Research Institute, San Diego, California, United States of America.
Show more
Source:
PLoS pathogens [PLoS Pathog] 2023 Aug 07; Vol. 19 (8), pp. e1011452. Date of Electronic Publication: 2023 Aug 07 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Envelope Protein gp41*/genetics
HIV Envelope Protein gp41*/metabolism
HIV-1*
Humans ; Glycosylation ; Mannose/metabolism ; Mutation ; Glycoproteins/metabolism ; HIV Envelope Protein gp120/genetics ; HIV Envelope Protein gp120/metabolism ; HIV Antibodies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Asymmetric conformations of cleaved HIV-1 envelope glycoprotein trimers in styrene-maleic acid lipid nanoparticles.
Authors:
Wang K; State Key Laboratory for Mesoscopic Physics, School of Physics, Peking University, Beijing, China.; Peking-Tsinghua Joint Center for Life Science, Peking University, Beijing, China.
Zhang S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Go EP; Department of Chemistry, University of Kansas, Lawrence, KS, USA.
Ding H; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Wang WL; State Key Laboratory for Mesoscopic Physics, School of Physics, Peking University, Beijing, China.
Nguyen HT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Microbiology, Harvard Medical School, Boston, MA, USA.
Kappes JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, USA.
Desaire H; Department of Chemistry, University of Kansas, Lawrence, KS, USA.
Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. joseph_.; Department of Microbiology, Harvard Medical School, Boston, MA, USA. joseph_.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. joseph_.
Mao Y; State Key Laboratory for Mesoscopic Physics, School of Physics, Peking University, Beijing, China. .; Peking-Tsinghua Joint Center for Life Science, Peking University, Beijing, China. .; Center for Quantitative Biology, Academy of Advanced Interdisciplinary Studies, Peking University, Beijing, China. .; National Biomedical Imaging Center, Peking University, Beijing, China. .
Show more
Source:
Communications biology [Commun Biol] 2023 May 18; Vol. 6 (1), pp. 535. Date of Electronic Publication: 2023 May 18.
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp41*/chemistry
HIV Envelope Protein gp41*/metabolism
HIV-1*/chemistry
Humans ; Protein Conformation ; Glycoproteins ; Styrenes
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Molecular Dynamics Investigation of Lipid-Specific Interactions with a Fusion Peptide.
Authors:
Heller WT; Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Show more
Source:
Biomolecules [Biomolecules] 2024 Feb 27; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 27.
Publication Type:
Journal Article
MeSH Terms:
Lipid Bilayers*/chemistry
HIV-1*/metabolism
Molecular Dynamics Simulation ; HIV Envelope Protein gp41/chemistry ; Peptides/chemistry
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay.
Authors:
Morozov V; Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA.; Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
Lagaye S; Centre de Recherche Saint-Antoine (CRSA), INSERM-UMR-S 938/Sorbonne Université, CEDEX 12, 75571 Paris, France.
Morozov A; Laboratory of Regulation of Intracellular Proteolysis, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 07; Vol. 23 (2). Date of Electronic Publication: 2022 Jan 07.
Publication Type:
Journal Article
MeSH Terms:
Antibodies, Monoclonal/*metabolism
Antibodies, Neutralizing/*metabolism
Broadly Neutralizing Antibodies/*metabolism
HIV Antibodies/*metabolism
HIV Envelope Protein gp41/*immunology
HIV-1/*immunology
Hydrolases/*metabolism
Animals ; Chlorocebus aethiops ; Epitopes/immunology ; HEK293 Cells ; HIV Envelope Protein gp41/chemistry ; HeLa Cells ; Hep G2 Cells ; Humans ; Hydrolases/chemistry ; Hydrolases/genetics ; Jurkat Cells ; Neutralization Tests ; Protein Domains ; Vero Cells
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
HIV-1 Envelope Conformation, Allostery, and Dynamics.
Authors:
Bennett AL; Duke Human Vaccine Institute, Durham, NC 27710, USA.
Henderson R; Duke Human Vaccine Institute, Durham, NC 27710, USA.; Department of Medicine, Duke University, Durham, NC 27710, USA.
Show more
Source:
Viruses [Viruses] 2021 May 07; Vol. 13 (5). Date of Electronic Publication: 2021 May 07.
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
HIV Envelope Protein gp41/*chemistry
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*metabolism
Antibodies, Neutralizing/immunology ; HIV Antibodies/immunology ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/immunology ; HIV-1/chemistry ; HIV-1/immunology ; Models, Molecular ; Protein Binding ; Protein Conformation ; Protein Multimerization ; Virus Internalization ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/immunology
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Thermostable chaperone-based polypeptide biosynthesis: Enfuvirtide model product quality and protocol-related impurities.
Authors:
Zenin V; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.
Tsedilin A; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.
Yurkova M; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.
Siniavin A; Ivanovsky Institute of Virology, N.F. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Fedorov A; Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.
Show more
Source:
PloS one [PLoS One] 2023 Jun 08; Vol. 18 (6), pp. e0286752. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV Fusion Inhibitors*/pharmacology
Humans ; Enfuvirtide/pharmacology ; Peptide Fragments/chemistry ; HIV Envelope Protein gp41/chemistry ; Peptides/chemistry
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies.
Authors:
Xu L; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Wang C; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Xu W; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Xing L; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Zhou J; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Pu J; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Fu M; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Lu L; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Jiang S; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Wang Q; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 05; Vol. 24 (11). Date of Electronic Publication: 2023 Jun 05.
Publication Type:
Journal Article
MeSH Terms:
HIV-1*
COVID-19*
HIV Infections*
HIV Fusion Inhibitors*/pharmacology
Humans ; Lipopeptides/pharmacology ; SARS-CoV-2 ; Anti-Retroviral Agents ; HIV Envelope Protein gp41
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Authors:
Ortiz R; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Barajas A; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.
Pons-Grífols A; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Trinité B; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.
Tarrés-Freixas F; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.
Rovirosa C; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.
Urrea V; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.
Barreiro A; HIPRA, 17170 Amer, Spain.
Gonzalez-Tendero A; HIPRA, 17170 Amer, Spain.
Cardona M; HIPRA, 17170 Amer, Spain.
Ferrer L; HIPRA, 17170 Amer, Spain.
Clotet B; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Infectious Diseases Department, Germans Trias I Pujol Hospital, 08916 Badalona, Spain.
Carrillo J; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; CIBERINFEC, ISCIII, 28029 Madrid, Spain.
Aguilar-Gurrieri C; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.
Blanco J; AIDS Research Institute, IrsiCaixa, Campus Can Ruti, 08916 Badalona, Spain.; Doctorate School, Microbiology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.; Doctorate School, Medicine Department, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; CIBERINFEC, ISCIII, 28029 Madrid, Spain.; Germans Trias I Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 May 19; Vol. 24 (10). Date of Electronic Publication: 2023 May 19.
Publication Type:
Journal Article
MeSH Terms:
Vaccines, Virus-Like Particle*
HIV-1*
Mice ; Animals ; Cats ; Leukemia Virus, Feline ; Mice, Inbred C57BL ; Retroviridae ; HIV Envelope Protein gp41
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.
Authors:
Cano-Muñoz M; Departamento de Química Física, Instituto de Biotecnología, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Cesaro S; Departamento de Química Física, Instituto de Biotecnología, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Morel B; Departamento de Química Física, Instituto de Biotecnología, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Lucas J; INSERM U1109, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, 67084 Strasbourg, France.
Moog C; INSERM U1109, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, 67084 Strasbourg, France.
Conejero-Lara F; Departamento de Química Física, Instituto de Biotecnología, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Show more
Source:
Biomolecules [Biomolecules] 2021 Apr 12; Vol. 11 (4). Date of Electronic Publication: 2021 Apr 12.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Molecular Docking Simulation*
Mutation*
HIV Envelope Protein gp41/*antagonists & inhibitors
Oligopeptides/*chemistry
Anti-HIV Agents/chemistry ; Anti-HIV Agents/pharmacology ; Binding Sites ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/metabolism ; Isoleucine/genetics ; Oligopeptides/genetics ; Oligopeptides/pharmacology ; Protein Binding ; Protein Stability
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies.
Authors:
Liu Q; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20852, USA.
Zhang P; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20852, USA.
Lusso P; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20852, USA.
Show more
Source:
Viruses [Viruses] 2021 Jul 20; Vol. 13 (7). Date of Electronic Publication: 2021 Jul 20.
Publication Type:
Journal Article; Research Support, N.I.H., Intramural; Review
MeSH Terms:
Virus Internalization*
Antibodies, Neutralizing/*metabolism
CD4 Antigens/*metabolism
HIV Antibodies/*metabolism
HIV Envelope Protein gp120/*metabolism
HIV Envelope Protein gp41/*metabolism
Binding Sites, Antibody ; Cell Line ; HIV Envelope Protein gp120/chemistry ; HIV Envelope Protein gp41/chemistry ; Humans ; Models, Molecular ; Protein Binding ; Protein Conformation ; Protein Multimerization ; Protein Structure, Quaternary/physiology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane.
Authors:
Wang C; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Li Q; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Sun L; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Wang X; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Wang H; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Zhang W; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.
Li J; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.; Key Laboratory of Structure-Based Drug Design and Discovery of the Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liu Y; Key Laboratory of Structure-Based Drug Design and Discovery of the Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lu L; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Jiang S; Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 131 Dong An Road, Shanghai 200032, China.
Show more
Source:
Viruses [Viruses] 2023 Apr 23; Vol. 15 (5). Date of Electronic Publication: 2023 Apr 23.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/metabolism
HIV Fusion Inhibitors*/pharmacology
HIV Fusion Inhibitors*/chemistry
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/metabolism
Humans ; HIV Envelope Protein gp41/chemistry ; Peptides/pharmacology ; Peptides/metabolism ; Glycoproteins/metabolism ; Cell Membrane/metabolism ; Receptors, CCR5/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Structure, membrane topology and influence of cholesterol of the membrane proximal region: transmembrane helical anchor sequence of gp41 from HIV.
Authors:
Aisenbrey C; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France.
Rifi O; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France.
Bechinger B; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France. .; Institut Universitaire de France, Paris, France. .
Show more
Source:
Scientific reports [Sci Rep] 2020 Dec 17; Vol. 10 (1), pp. 22278. Date of Electronic Publication: 2020 Dec 17.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholesterol/*chemistry
HIV Envelope Protein gp41/*ultrastructure
HIV Infections/*genetics
HIV-1/*ultrastructure
Amino Acid Sequence/genetics ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV Infections/physiopathology ; HIV Infections/virology ; HIV-1/chemistry ; Humans ; Peptides/chemistry ; Peptides/genetics ; Protein Structure, Secondary
Academic Journal
Full Text  Link opens in a new windowDetails
Title:
Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.
Authors:
Geng X; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Liu Z; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Yu D; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Qin B; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Zhu Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Cui S; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Chong H; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. .; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. .
He Y; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. .; Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. .
Show more
Source:
Viruses [Viruses] 2019 Jul 03; Vol. 11 (7). Date of Electronic Publication: 2019 Jul 03.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Retroviral Agents/*pharmacology
HIV Envelope Protein gp41/*drug effects
HIV Envelope Protein gp41/*metabolism
HIV-1/*drug effects
Virus Internalization/*drug effects
Amino Acid Sequence ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; HIV-1/physiology ; Membrane Fusion/drug effects ; Models, Molecular ; Mutagenesis, Site-Directed ; Mutation ; Peptides/chemistry ; Peptides/pharmacology ; Structure-Activity Relationship
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Neutralizing Antibodies Targeting HIV-1 gp41.
Authors:
Caillat C; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Guilligay D; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Sulbaran G; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Weissenhorn W; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Show more
Source:
Viruses [Viruses] 2020 Oct 23; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 23.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antibodies, Neutralizing/*chemistry
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp41/*immunology
AIDS Vaccines/immunology ; Animals ; Epitopes/immunology ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; HIV-1/immunology ; Humans ; Mice ; Mutation
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Targeting a Conserved Lysine in the Hydrophobic Pocket of HIV-1 gp41 Improves Small Molecule Antiviral Activity.
Authors:
He L; Department of Basic Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.
Zhou G; Department of Basic Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.
Sofiyev V; Department of Basic Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.
Garcia E; Master of Science in Medical Health Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.
Nguyen N; Master of Science in Medical Health Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.
Li KH; Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, San Francisco, CA 94143, USA.
Gochin M; Department of Basic Sciences, Touro University California College of Osteopathic Medicine, 1310 Club Drive, Mare Island, Vallejo, CA 94592, USA.; Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, San Francisco, CA 94143, USA.
Show more
Source:
Viruses [Viruses] 2022 Dec 02; Vol. 14 (12). Date of Electronic Publication: 2022 Dec 02.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Fusion Inhibitors*/pharmacology
HIV Fusion Inhibitors*/chemistry
HIV-1*/metabolism
Humans ; Antiviral Agents/pharmacology ; Antiviral Agents/metabolism ; Lysine/metabolism ; HIV Envelope Protein gp41/chemistry ; Hydrophobic and Hydrophilic Interactions
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope.
Authors:
Torralba J; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
de la Arada I; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Partida-Hanon A; Institute of Physical Chemistry 'Rocasolano' (IQFR-CSIC), Serrano 119, E-28006, Madrid, Spain.
Rujas E; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Ikerbasque, Basque Foundation for Science, 48013, Bilbao, Spain.; Pharmacokinetic, Nanotechnology and Gene Therapy Group, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz, Spain.; Bioaraba, Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, 01006, Vitoria-Gasteiz, Spain.
Arribas M; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Insausti S; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.
Valotteau C; Laboratoire Adhesion et Inflammation, INSERM U1067, CNRS UMR 7333, Aix-Marseille Université, Turing Centre for Living systems, Marseille, France.
Valle J; Laboratory of Proteomics and Protein Chemistry, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003, Barcelona, Spain.
Andreu D; Laboratory of Proteomics and Protein Chemistry, Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Dr. Aiguader 88, 08003, Barcelona, Spain.
Caaveiro JMM; Laboratory of Global Healthcare, School of Pharmaceutical Sciences, Kyushu University, Fukuoka, 819-0395, Japan.
Jiménez MA; Institute of Physical Chemistry 'Rocasolano' (IQFR-CSIC), Serrano 119, E-28006, Madrid, Spain.
Apellániz B; Department of Physiology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad, 7, 01006, Vitoria-Gasteiz, Spain. .
Redondo-Morata L; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017/CIIL-Centre d'Infection et d'Immunité de Lille, F-59000, Lille, France. .
Nieva JL; Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. .; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain. .
Show more
Source:
Communications biology [Commun Biol] 2022 Nov 18; Vol. 5 (1), pp. 1265. Date of Electronic Publication: 2022 Nov 18.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/chemistry
HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/metabolism ; HIV Antibodies/chemistry ; Epitopes ; Lipid Bilayers/chemistry
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
Authors:
Joshi VR; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Department of Virology, Harvard Medical School, Boston, Massachusetts, United States of America.
Newman RM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Pack ML; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Power KA; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Munro JB; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Okawa K; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Madani N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Sodroski JG; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Schmidt AG; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Allen TM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Show more
Source:
PLoS pathogens [PLoS Pathog] 2020 May 11; Vol. 16 (5), pp. e1008577. Date of Electronic Publication: 2020 May 11 (Print Publication: 2020).
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp41*/antagonists & inhibitors
HIV Envelope Protein gp41*/immunology
Antibodies, Neutralizing/*pharmacology
HIV Antibodies/*pharmacology
HIV Infections/*immunology
HIV-1/*immunology
Virus Internalization/*drug effects
Antibodies, Neutralizing/immunology ; CD4 Antigens/immunology ; HEK293 Cells ; HIV Antibodies/immunology ; HIV Infections/drug therapy ; HIV Infections/pathology ; Humans
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates.
Authors:
Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
van Schooten J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bowman CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Oyen D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Shin M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Morpurgo R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van der Woude P; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Breemen M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Patel R; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Gross J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Copps J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
Nogal B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
Sok D; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Rakasz EG; Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, United States of America.
Labranche C; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Vigdorovich V; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Christley S; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America.
Carnathan DG; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Sather DN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Montefiori D; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Silvestri G; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Burton DR; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Show more
Source:
PLoS pathogens [PLoS Pathog] 2020 Aug 31; Vol. 16 (8), pp. e1008753. Date of Electronic Publication: 2020 Aug 31 (Print Publication: 2020).
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Epitope Mapping*
AIDS Vaccines/*immunology
Epitopes/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp120/*immunology
HIV Envelope Protein gp41/*immunology
HIV-1/*immunology
AIDS Vaccines/genetics ; Animals ; Antibodies, Monoclonal, Murine-Derived/immunology ; Epitopes/genetics ; HIV Antibodies/genetics ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; Macaca mulatta ; Protein Multimerization/genetics ; Protein Multimerization/immunology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies.
Authors:
Zhu H; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, United States of America.
Mathew E; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, United States of America.
Connelly SM; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, United States of America.
Zuber J; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, United States of America.
Sullivan M; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States of America.
Piepenbrink MS; Infectious Diseases Division, University of Rochester Medical Center, Rochester, NY United States of America.
Kobie JJ; Infectious Diseases Division, University of Rochester Medical Center, Rochester, NY United States of America.
Dumont ME; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, United States of America.
Show more
Source:
PloS one [PLoS One] 2019 Sep 10; Vol. 14 (9), pp. e0221550. Date of Electronic Publication: 2019 Sep 10 (Print Publication: 2019).
Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibody Affinity*
Mutation*
Antibodies, Neutralizing/*immunology
HIV Envelope Protein gp41/*immunology
Protein Precursors/*immunology
Antibodies, Viral/immunology ; Epitopes/chemistry ; Epitopes/genetics ; Epitopes/immunology ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; Protein Binding ; Protein Precursors/chemistry ; Protein Precursors/genetics ; Protein Stability
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
Authors:
Martínez-García D; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08905 Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Pérez-Hernández M; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08905 Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Korrodi-Gregório L; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08905 Barcelona, Spain.
Quesada R; Department of Chemistry, Universidad de Burgos, 09001 Burgos, Spain.
Ramos R; Department of Thoracic Surgery and University of Barcelona, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Baixeras N; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Pérez-Tomás R; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08905 Barcelona, Spain.; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Soto-Cerrato V; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, 08905 Barcelona, Spain. .; Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain. .
Show more
Source:
Biomolecules [Biomolecules] 2019 Aug 13; Vol. 9 (8). Date of Electronic Publication: 2019 Aug 13.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Biological Products/*pharmacology
Carcinoma, Non-Small-Cell Lung/*drug therapy
HIV Envelope Protein gp41/*pharmacology
Lung Neoplasms/*drug therapy
Peptide Fragments/*pharmacology
STAT3 Transcription Factor/*antagonists & inhibitors
Survivin/*antagonists & inhibitors
Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Biological Products/chemical synthesis ; Biological Products/chemistry ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cells, Cultured ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; HIV Envelope Protein gp41/chemical synthesis ; HIV Envelope Protein gp41/chemistry ; Humans ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Molecular Structure ; Peptide Fragments/chemical synthesis ; Peptide Fragments/chemistry ; STAT3 Transcription Factor/metabolism ; Structure-Activity Relationship ; Survivin/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 2173 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.